High impact
[Ohio] Requirements for Including National Drug Code
CareSource·Effective Jul 25, 2025
HCPCS S0145 is officially defined as "Injection, pegylated interferon alfa-2a, 180 mcg per ml." HCPCS S0145 is referenced in 1 tracked payer policy change from CareSource. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS S0145 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.